Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S, API-CAT Investigators

Open source

DOI: 10.1056/nejmoa2416112
Published: 2025 Apr 10
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2416112,
  title = {Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.},
  author = {Mahé I and Carrier M and Mayeur D and Chidiac J and Vicaut E and Falvo N and Sanchez O and Grange C and Monreal M and López-Núñez JJ and Otero-Candelera R and Le Gal G and Yeo E and Righini M and Robert-Ebadi H and Huisman MV and Klok FA and Westerweel P and Agnelli G and Becattini C and Bamias A and Syrigos K and Szmit S and Torbicki A and Verhamme P and Maraveyas A and Cohen AT and Ay C and Chapelle C and Meyer G and Couturaud F and Mismetti P and Girard P and Bertoletti L and Laporte S and API-CAT Investigators},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2416112},
  url = {https://doi.org/10.1056/nejmoa2416112}
}

RIS

TY  - JOUR
TI  - Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
AU  - Mahé I
AU  - Carrier M
AU  - Mayeur D
AU  - Chidiac J
AU  - Vicaut E
AU  - Falvo N
AU  - Sanchez O
AU  - Grange C
AU  - Monreal M
AU  - López-Núñez JJ
AU  - Otero-Candelera R
AU  - Le Gal G
AU  - Yeo E
AU  - Righini M
AU  - Robert-Ebadi H
AU  - Huisman MV
AU  - Klok FA
AU  - Westerweel P
AU  - Agnelli G
AU  - Becattini C
AU  - Bamias A
AU  - Syrigos K
AU  - Szmit S
AU  - Torbicki A
AU  - Verhamme P
AU  - Maraveyas A
AU  - Cohen AT
AU  - Ay C
AU  - Chapelle C
AU  - Meyer G
AU  - Couturaud F
AU  - Mismetti P
AU  - Girard P
AU  - Bertoletti L
AU  - Laporte S
AU  - API-CAT Investigators
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2416112
UR  - https://doi.org/10.1056/nejmoa2416112
ER  -

APA

I, M., M, C., D, M., J, C., E, V., N, F., O, S., C, G., M, M., JJ, L., R, O., G, L. G., E, Y., M, R., H, R., MV, H., FA, K., P, W., G, A., C, B., A, B., K, S., S, S., A, T., P, V., A, M., AT, C., C, A., C, C., G, M., F, C., P, M., P, G., L, B., S, L., & Investigators, A. (2025). Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2416112

Source records

pubmed · retrieved 2026-09-26T22:53:41.294Z